| ID | Assay | Related subunit | Celltype | Tissue | Disease | Treatment1 | Treatment2 | Study | Download1 | Download2 |
|---|---|---|---|---|---|---|---|---|---|---|
| CDBD00719 | ChIPseq | SA1 | MCF-7 | Breast | Cancer | siCtrl | NT | GSE25021 | ||
| CDBD00718 | ChIPseq | SA1 | MCF-7 | Breast | Cancer | siCTCF | NT | GSE25021 | ||
| CDBD00717 | ChIPseq | SA1 | MCF-7 | Breast | Cancer | E2- | NT | GSE25021 | ||
| CDBD00716 | ChIPseq | SA1 | MCF-7 | Breast | Cancer | E2+ | NT | GSE25021 | ||
| CDBD00700 | ChIPseq | SA1 | Hep-G2 | Liver | Cancer | NT | NT | GSE25021 | ||
| CDBD00549 | ChIPseq | SA1 | Hela-Kyoto | Cervix | Cancer | NT | NT | GSE138405 | ||
| CDBD00548 | ChIPseq | SA1 | Hela-Kyoto | Cervix | Cancer | NT | NT | GSE138405 | ||
| CDBD00493 | ChIPseq | SA1 | HL-60 | Blood | Cancer | NT | NT | GSE131577 | ||
| CDBD00492 | ChIPseq | SA1 | HL-60 | Blood | Cancer | NT | NT | GSE131577 | ||
| CDBD00474 | ChIPseq | SA1 | Hela-Kyoto | Cervix | Cancer | NT | NT | GSE126990 | ||
| CDBD00390 | ChIPseq | SA1 | RT-112 | Bladder | Cancer | NT | NT | GSE111913 | ||
| CDBD00389 | ChIPseq | SA1 | RT-112 | Bladder | Cancer | NT | NT | GSE111913 | ||
| CDBD00385 | ChIPseq | SA1 | OCI-AML-3 | Blood | Cancer | NT | siSA2 | GSE111537 | ||
| CDBD00384 | ChIPseq | SA1 | OCI-AML-3 | Blood | Cancer | NT | NT | GSE111537 | ||
| CDBD00173 | ChIPseq | SA1 | Hep-G2 | Liver | Cancer | NT | CRISPR-SA1 | ENCSR167MTG | ||
| CDBD00172 | ChIPseq | SA1 | Hep-G2 | Liver | Cancer | NT | CRISPR-SA1 | ENCSR167MTG | ||
| CDBD00171 | ChIPseq | SA1 | K-562 | Blood | Cancer | NT | CRISPR-SA1 | ENCSR153HNT | ||
| CDBD00170 | ChIPseq | SA1 | K-562 | Blood | Cancer | NT | CRISPR-SA1 | ENCSR153HNT |